https://marketrealist.com/2016/05/medivation-sees-growth-xtandi-major-oncology-drug/
Medivation Sees Growth in Xtandi: A Major Oncology Drug
May 10, 2016 - Medivation (MDVN) is an oncology-focused biopharmaceutical company, and Xtandi as its only approved drug.
a majormedivationseesgrowthxtandi
https://www.fool.com/investing/2016/08/23/what-pfizer-gets-in-its-14-billion-medivation-deal.aspx
What Pfizer Gets in Its $14 Billion Medivation Deal | The Motley Fool
Aug 23, 2016 - Pfizer is paying $81.50 per share in cash to acquire Medivation's oncology drugs.
https://www.latimes.com/business/la-fi-pfizer-medivation-acquisition-20160822-snap-story.html
Pfizer to pay $14 billion for Medivation, whose drug Xtandi was discovered by UCLA - Los Angeles...
Aug 23, 2016 - Pharmaceutical giant Pfizer Inc. is paying $14 billion to buy Medivation Inc., a San Francisco biotech company that sells a high-priced prostate cancer...
https://www.biospace.com/medivation-inc-begins-phase-1-2a-trial-of-dimebon-tm-in-huntington-s-disease
Medivation, Inc. Begins Phase 1-2a Trial Of Dimebon(TM) In Huntington's Disease - BioSpace
https://www.wcpo.com/news/national/pfizer-to-buy-medivation-for-14b
Pfizer to buy Medivation for $14B
Aug 22, 2016 - Pfizer will pay about $14 billion to acquire the cancer drug company Medivation.
to buypfizermedivation
https://www.biospace.com/medivation-inc-announces-offering-of-2-750-000-shares-of-common-stock
Medivation, Inc. Announces Offering of 2,750,000 Shares of Common Stock - BioSpace
medivation incof 2
https://www.fiercebiotech.com/biotech/david-hung-and-ex-medivation-execs-join-forces-for-stealthy-cancer-startup
Hung, ex-Medivation execs join forces for stealthy cancer startup | Fierce Biotech
join forces